GSK up 6% after drawing a line under Zantac litigation saga
GSK agrees $2.2 billion settlementRemoves 93% of outstanding casesStock overhang removedEmbattled pharmaceutical giant GSK (GSK) has agreed to pay up to $2.2 billion (£1.8 billion) to settle lawsuits in the US related to its Zantac...
10 October 2024
